117 related articles for article (PubMed ID: 38877363)
21. Clinical utility of preoperative pan-immune-inflammation value (PIV) for prognostication in patients with esophageal squamous cell carcinoma.
Feng J; Wang L; Yang X; Chen Q; Cheng X
Int Immunopharmacol; 2023 Oct; 123():110805. PubMed ID: 37591121
[TBL] [Abstract][Full Text] [Related]
22. Correlation between inflammatory markers over time and disease severity in status epilepticus: a preliminary study.
Shi X; Zhang X; Song S; Pan H; Huang C; Sun T; Wang S; Xu J
Front Neurol; 2024; 15():1334415. PubMed ID: 38370523
[TBL] [Abstract][Full Text] [Related]
23. Prognostic role of the systemic immune-inflammation index and pan-immune inflammation value for outcomes of breast cancer: a systematic review and meta-analysis.
Cheng HW; Wang T; Yu GC; Xie LY; Shi B
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(1):180-190. PubMed ID: 38235869
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of systemic inflammatory and nutritional indexes in locally advanced gastric cancer treated with adjuvant chemoradiotherapy after D2 dissection.
Wang SB; Chen JY; Xu C; Cao WG; Cai R; Cao L; Cai G
Front Oncol; 2022; 12():1040495. PubMed ID: 36387250
[TBL] [Abstract][Full Text] [Related]
25. A Novel Prognostic Model Using Pan-Immune-Inflammation Value and Programmed Death Ligand 1 in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Receiving Immune Checkpoint Inhibitors: A Retrospective Multicenter Analysis.
Lien MY; Hwang TZ; Wang CC; Hsieh CY; Yang CC; Wang CC; Lien CF; Shih YC; Yeh SA; Hsieh MC
Target Oncol; 2024 Jan; 19(1):71-79. PubMed ID: 38041732
[TBL] [Abstract][Full Text] [Related]
26. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma.
Gao Y; Guo W; Cai S; Zhang F; Shao F; Zhang G; Liu T; Tan F; Li N; Xue Q; Gao S; He J
J Cancer; 2019; 10(14):3188-3196. PubMed ID: 31289589
[No Abstract] [Full Text] [Related]
27. High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab.
Jiang L; Fang J; Ding J
Cancer Manag Res; 2020; 12():475-484. PubMed ID: 32021460
[TBL] [Abstract][Full Text] [Related]
28. High pre-chemoradiotherapy pan-immune-inflammation value levels predict worse outcomes in patients with stage IIIB/C non-small-cell lung cancer.
Topkan E; Kucuk A; Ozkan EE; Ozturk D; Besen AA; Mertsoylu H; Pehlivan B; Selek U
Discov Oncol; 2023 Dec; 14(1):230. PubMed ID: 38091179
[TBL] [Abstract][Full Text] [Related]
29. Association between a four-parameter inflammatory index and all-cause mortality in critical ill patients with non-traumatic subarachnoid hemorrhage: a retrospective analysis of the MIMIC-IV database (2012-2019).
Huang YW; Zhang Y; Li ZP; Yin XS
Front Immunol; 2023; 14():1235266. PubMed ID: 37936706
[TBL] [Abstract][Full Text] [Related]
30. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
[No Abstract] [Full Text] [Related]
31. The prognostic value of the preoperative inflammatory index on the survival of glioblastoma patients.
Shi X; Li H; Xu Y; Nyalali AMK; Li F
Neurol Sci; 2022 Sep; 43(9):5523-5531. PubMed ID: 35606674
[TBL] [Abstract][Full Text] [Related]
32. Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitors.
Yazgan SC; Yekedüz E; Utkan G; Ürün Y
Prostate; 2022 Nov; 82(15):1456-1461. PubMed ID: 35899494
[TBL] [Abstract][Full Text] [Related]
33. Pan-Immune-Inflammation Index as a Biomarker for Rheumatoid Arthritis Progression and Diagnosis.
Tutan D; Doğan AG
Cureus; 2023 Oct; 15(10):e46609. PubMed ID: 37808603
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of peripheral blood neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, pan-immune-inflammation value and systemic immune-inflammation index for the efficacy of immunotherapy in patients with advanced gastric cancer.
Fu M; Zhang X; Shen F; Ma J; Li Z
Immunotherapy; 2024 Apr; ():. PubMed ID: 38578121
[TBL] [Abstract][Full Text] [Related]
35. Postoperative Systemic Immune-Inflammation Index (SII): A Superior Prognostic Factor of Endometrial Cancer.
Huang Y; Chen Y; Zhu Y; Wu Q; Yao C; Xia H; Li C
Front Surg; 2021; 8():704235. PubMed ID: 34746222
[No Abstract] [Full Text] [Related]
36. Blood-based biomarkers: diagnostic value in brain tumors (focus on gliomas).
Yang Y; Hu F; Wu S; Huang Z; Wei K; Ma Y; Ou-Yang Q
Front Neurol; 2023; 14():1297835. PubMed ID: 37936915
[TBL] [Abstract][Full Text] [Related]
37. The Pan-Immune-Inflammation-Value Predicts the Survival of Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Breast Cancer Treated with First-Line Taxane-Trastuzumab-Pertuzumab.
Ligorio F; Fucà G; Zattarin E; Lobefaro R; Zambelli L; Leporati R; Rea C; Mariani G; Bianchi GV; Capri G; de Braud F; Vernieri C
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921727
[TBL] [Abstract][Full Text] [Related]
38. A high pan-immune-inflammation value before chemoradiotherapy indicates poor outcomes in patients with small-cell lung cancer.
Kucuk A; Topkan E; Ozkan EE; Ozturk D; Pehlivan B; Selek U
Int J Immunopathol Pharmacol; 2023; 37():3946320231187759. PubMed ID: 37404137
[No Abstract] [Full Text] [Related]
39. Nomogram Based on Systemic Immune-Inflammation Index to Predict Survival of Tongue Cancer Patients Who Underwent Cervical Dissection.
Lu Z; Yan W; Liang J; Yu M; Liu J; Hao J; Wan Q; Liu J; Luo C; Chen Y
Front Oncol; 2020; 10():341. PubMed ID: 32219070
[No Abstract] [Full Text] [Related]
40. The prognostic value of inflammation markers in postoperative gliomas with or without adjuvant treatments.
Luo Y; Deng R; Zhong Q; Luo D; Li X; Chen X; Tao S; Feng Z; Jiayi L; Huang Y; Li J; Liu W
Medicine (Baltimore); 2021 Jun; 100(25):e26437. PubMed ID: 34160435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
